What happens when you take grapefruit with sirolimus?
Sirolimus (brand name Rapamune; also known as rapamycin) is an mTOR-inhibiting immunosuppressant used to prevent rejection after kidney transplant and to treat lymphangioleiomyomatosis. Grapefruit blocks one of the main systems your body uses to control how much sirolimus reaches your bloodstream, so the same dose can produce much higher, and far less predictable, blood levels.
- Sirolimus is cleared by two gut systems. It is broken down by the CYP3A4 enzyme in the gut wall and liver, and pumped back out of intestinal cells by a transporter called P-glycoprotein (P-gp). Together these systems normally limit how much of each dose is absorbed.
- Grapefruit disables them. Grapefruit contains compounds called furanocoumarins (such as bergamottin) that irreversibly inactivate intestinal CYP3A4 and partially block P-glycoprotein.
- More drug gets through. With both systems impaired, more of the sirolimus dose survives the gut wall and is absorbed, raising blood levels.
- The rise is unpredictable. The effect varies from person to person and from one exposure to the next, so no clinician can reliably dose around it. The FDA Rapamune label therefore states that grapefruit juice must not be taken with, or used to dilute, the drug.
Why is this important?
Sirolimus is a classic example of a narrow therapeutic window drug: there is only a small gap between a blood level that protects the transplant and one that causes harm. If the level is too low, the body can reject the organ; if it is too high, the patient can develop serious toxicity.
Supratherapeutic sirolimus levels can cause kidney injury, infection, raised blood fats, low platelet and red-cell counts, raised blood sugar, mouth ulcers, lung inflammation (pneumonitis), and impaired wound healing.
Patient-to-patient variation in sirolimus exposure is already wide before any food interaction. Adding grapefruit's effect on top of that variability is what makes the combination dangerous: a previously stable regimen can be destabilised by an exposure that cannot be measured in advance. For a transplant recipient, the consequences of getting this wrong can include loss of the graft; for someone with lymphangioleiomyomatosis, excess sirolimus can cause lung inflammation that may be mistaken for the disease itself.
What should you do?
The principle is simple: treat grapefruit and its close relatives as off-limits for as long as you take sirolimus.
Before any change to your diet or medicines: tell your transplant team and pharmacist that you take sirolimus before adding any new food, juice, or supplement. Flag grapefruit alongside other known CYP3A4 interactors (for example certain antifungals, some antibiotics, certain blood-pressure medicines, and St. John's wort) so the full picture is on file.
Every day on sirolimus: avoid grapefruit, grapefruit juice, pomelo (Chinese grapefruit), Seville (sour) oranges, tangelos, and minneolas completely. Read marmalade and citrus-blend juice labels, since Seville oranges are common ingredients. Sweet oranges, mandarins, clementines, lemons, and limes are safe. If you take Rapamune oral solution, dilute it only as the label permits (water or orange juice) and never with grapefruit juice.
After an accidental exposure: contact your transplant coordinator or prescriber the same day. Do not skip or self-adjust your sirolimus dose. Your team will decide, based on a measured blood level, whether any change is needed. Watch for new mouth sores, swelling in the legs or face, shortness of breath, fever, easy bruising, or a rise in kidney-function results on routine labs, and report them promptly.
Which specific products are affected?
All oral forms of sirolimus are affected, because the interaction happens at the intestinal CYP3A4 enzyme and P-glycoprotein transporter — any swallowed dose is at risk. This includes Rapamune tablets, Rapamune oral solution, and generic sirolimus tablets.
The same caution applies to everolimus (Afinitor, Zortress), a closely related mTOR inhibitor with nearly identical dependence on CYP3A4 and P-gp. Tacrolimus (Prograf) and cyclosporine (Neoral, Sandimmune, Gengraf) are also strongly affected by grapefruit and are often co-prescribed with sirolimus, so the combined risk is highest for patients on multidrug immunosuppression.
On the food side, the items to avoid are grapefruit (fresh fruit), grapefruit juice, pomelo, Seville (sour) oranges, tangelos and minneolas, marmalade made with Seville oranges, and citrus-blend juices that contain grapefruit or Seville orange.
The science behind it
The strongest evidence here is regulatory rather than a single trial. The FDA-approved Rapamune (sirolimus) prescribing information states directly that grapefruit juice inhibits the CYP3A4-mediated metabolism of sirolimus and "must not be taken with or be used for dilution of Rapamune," and identifies sirolimus as a CYP3A4 and P-glycoprotein substrate with a narrow therapeutic index.
The European Medicines Agency (EMA) Rapamune Product Information reaches the same conclusion independently, advising that grapefruit juice affects CYP3A4-mediated metabolism and should be avoided, and confirming sirolimus's status as a CYP3A4 and P-gp substrate. Two major regulators converging on an outright avoidance instruction — rather than a cautious dose adjustment — is itself the signal: the interaction is considered large enough and unpredictable enough that no safe quantity has been defined.
Frequently Asked Questions
Is it only grapefruit juice, or the fruit too?
Both. Fresh grapefruit and grapefruit juice both contain the furanocoumarins responsible for the interaction. Avoid the fruit in any form.
What about pomelo and Seville oranges?
Avoid them. Pomelo (Chinese grapefruit) and Seville (sour) oranges, along with tangelos and minneolas, contain the same or similar compounds and should be treated the same way as grapefruit. Seville oranges are commonly used in marmalade and some blended juices.
Are regular oranges and other citrus safe?
Yes. Sweet (navel/Valencia) oranges, mandarins, clementines, lemons, and limes do not meaningfully affect sirolimus and are fine.
How long after grapefruit do I need to wait?
Spacing does not solve the problem. Grapefruit inactivates the gut enzyme for an extended period, so simply taking your dose a few hours apart is not protective. The safe approach is to avoid grapefruit entirely rather than try to time around it.
I accidentally drank grapefruit juice — what now?
Contact your transplant team or prescriber the same day. Do not skip or change your dose on your own. They can check a blood level and decide whether anything needs to change.
Can I use grapefruit juice to make the oral solution taste better?
No. Never use grapefruit juice to dilute or mask the taste of sirolimus oral solution. Use only the diluent your label permits, such as water or orange juice.
Key takeaways
- Both the FDA and EMA labels say to avoid grapefruit with sirolimus — this is an explicit prohibition, not just a caution.
- Grapefruit blocks the CYP3A4 enzyme and P-glycoprotein, raising sirolimus blood levels unpredictably.
- Sirolimus has a narrow therapeutic window, so unplanned increases can cause toxicity and threaten the transplant.
- Avoid grapefruit, grapefruit juice, pomelo, Seville oranges, tangelos, and minneolas completely; sweet oranges, mandarins, lemons, and limes are fine.
- Never use grapefruit juice to dilute the oral solution.
- After accidental exposure, call your team the same day and let a measured blood level guide any change — do not self-adjust.